Synthetic Biologics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.10.18	IMDZ Discontinues SYNOVATE, FDA Delays Decision On ADMA's Bivigam, TRVN Snubbed (RTTNews)
15.08.18	OptiNose Dives To New Low, ReWalk Tumbles, SYN Down 60% This Month (RTTNews)
14.08.18	SYN Tumbles To New Low, ASNS Down 27% This Month, INNT On Watch (RTTNews)
02.08.18	ARQL Lifts 2018 Outlook, AXGN Q2 Revenue Up 36%, RXII Catches Eyes (RTTNews)
22.05.18	Synthetic Biologics Announces Acceptance of Compliance Plan by NYSE American (PR Newswire)
08.05.18	Synthetic Biologics Reports First Quarter 2018 Operational Highlights and Financial Results (PR Newswire)
26.04.18	Synthetic Biologics to Report First Quarter 2018 Operational Highlights and Financial Results on May 8, 2018 (PR Newswire)
23.04.18	Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection (PR Newswire)
10.04.18	Advice for Safeguarding Your Home Against Lightning Damage (PR Newswire)
05.04.18	Syncordia Technologies and Healthcare Solutions, Corp. Announces Collateral Agent Demand Letter Notice of Intention to Enforce Security (PR Newswire)
05.04.18	Syncordia Technologies and Healthcare Solutions, Corp. Announces Collateral Agent Demand Letter Notice of Intention to Enforce Security (PR Newswire)
05.04.18	IIROC Trading Halt - SYN (PR Newswire)
05.04.18	IIROC Trading Halt - SYN (PR Newswire)
07.03.18	Synthetic Biologics Reports on NYSE American Noncompliance Notice and Compliance Plan (PR Newswire)
22.02.18	Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results (PR Newswire)
15.02.18	Synthetic Biologics to Report 2017 Year End Operational Highlights and Financial Results on February 22, 2018 (PR Newswire)
25.01.18	Don't Get Scammed - Do Your Research (PR Newswire)
24.01.18	Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple... (PR Newswire)
05.01.18	Syncordia Technologies and Healthcare Solutions, Corp. Announces Signing of a Debt Term Sheet for up to $16.5million (PR Newswire)
05.01.18	Syncordia Technologies and Healthcare Solutions, Corp. Announces Signing of a Debt Term Sheet for up to $16.5million (PR Newswire)
04.01.18	Syncordia Technologies and Healthcare Solutions, Corp. Announces Organic Growth, Blockchain Offering, Addition to Board of Directors and Anticipated Timing for Elimination of Existing Debt (PR Newswire)
04.01.18	Syncordia Technologies and Healthcare Solutions, Corp. Announces Organic Growth, Blockchain Offering, Addition to Board of Directors and Anticipated Timing for Elimination of Existing Debt (PR Newswire)
02.01.18	Synthetic Biologics to Present at the Biotech Showcase™ 2018 Conference (PR Newswire)
20.12.17	Syncordia Technologies and Healthcare Solutions, Corp. Announces an Initial Agreement to General Deal Terms for a Debt Refinancing (PR Newswire)
20.12.17	Syncordia Technologies and Healthcare Solutions, Corp. Announces an Initial Agreement to General Deal Terms for a Debt Refinancing (PR Newswire)
05.12.17	Synthetic Biologics Announces Management Changes (PR Newswire)
29.11.17	Syncordia Technologies and Healthcare Solutions, Corp. Reports Second Quarter Fiscal 2018 Results (PR Newswire)
29.11.17	Syncordia Technologies and Healthcare Solutions, Corp. Reports Second Quarter Fiscal 2018 Results (PR Newswire)
15.11.17	Reitmans (Canada) Limited welcomes Jonathon Fitzgerald to its executive team as Group President to lead plus-size brands Addition Elle and Penningtons (PR Newswire)
01.11.17	Synthetic Biologics Reports Third Quarter 2017 Operational Highlights and Financial Results (PR Newswire)
31.10.17	Les rapports financiers des partis politiques enregistrés pour le troisième trimestre de 2017 sont maintenant en ligne (PR Newswire)
25.10.17	Synthetic Biologics to Report Third Quarter 2017 Operational Highlights and Financial Results on November 1, 2017 (PR Newswire)
16.10.17	Sodexo et l'Université d'Ottawa souhaitent rendre leurs sens aux seniors (PR Newswire)
12.10.17	De nouveaux outils pour les chercheurs canadiens de renom - Plus de 20 millions de dollars accordes a l'Universite de Calgary pour de nouveaux laboratoires et equipements qui aideront les... (PR Newswire)
02.10.17	Cees van Gent Appointed CEO of JF Hillebrand Group (PR Newswire)
01.10.17	Record-breaking Invictus Games reaches new heights, inspiring wounded warriors with biggest Games yet (PR Newswire)
28.09.17	Aytu BioScience to Webcast, Live, at VirtualInvestorConferences.com on October 5th (PR Newswire)
20.09.17	Home Capital Group Inc. Files Preliminary Universal Base Shelf Prospectus (PR Newswire)
12.09.17	Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing (PR Newswire)
29.08.17	Synthetic Biologics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12, 2017 (PR Newswire)
09.08.17	Daily Technical Summary Reports on Biotech Stocks -- Axovant Sciences, Ampio Pharma, ImmunoCellular Therapeutics, and Synthetic Biologics (PR Newswire)
03.08.17	Synthetic Biologics Reports Second Quarter 2017 Operational Highlights and Financial Results (PR Newswire)
27.07.17	Synthetic Biologics to Report Second Quarter 2017 Operational Highlights and Financial Results on August 3, 2017 (PR Newswire)
27.06.17	Synthetic Biologics Announces Allowance of Key U.S. Patent Covering SYN-010 Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) (PR Newswire)
11.05.17	SYN-004 (Ribaxamase) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Prevention of Clostridium difficile Infection (PR Newswire)
08.05.17	Asia-Pacific Online Payment Methods Report 2017: Full Year 2016 Data - Shoppers in Asia-Pacific Enjoy the Convenience of Mobile Payment - Research and Markets (PR Newswire)
04.05.17	Synthetic Biologics Reports First Quarter 2017 Operational Highlights and Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	53.56	3.72 %	K V
Sonova Hldg	318.50	3.11 %	K V
Part Grp Hldg	1’381.00	2.30 %	K V
Alcon	80.90	1.81 %	K V
Lonza Grp	580.40	1.79 %	K V
Nestle	74.18	-0.75 %	K V
Geberit	500.80	-0.91 %	K V
Kuehne+Nagel Int	204.60	-1.06 %	K V
Swisscom	506.50	-1.65 %	K V
Logitech Intl	79.90	-1.75 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Synthetic Biologics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten